The national capital's stock of anti-coronavirus vaccine will only last for eight days, according to a vaccination bulletin issued by the Delhi government on Thursday.
As of Thursday morning, the balance stock of the vaccines--Covaxin and Covishield--were 3,37,670 and 5,76,490 doses, respectively.
The bulletin noted that 48,260 doses of Covaxin and 3,29,390 doses of Covishield were added to the stock on Wednesday.
In all, the Delhi government has received 1,07,98,960 doses of vaccine to date, out of which, 27,33,660 doses were of Covaxin, and the remaining Covishield.
The city has administered 1,11,03,991 doses of vaccine, including those given at private facilities, out of which, 80,02,411 were first doses and 31,01,580 second jabs.
On Wednesday, 1,15,801 vaccine doses were administered. Of these, 71,532 were first doses and 44,269 were second ones, the bulletin said.
Delhi's current vaccination capacity is 1,77,496 doses per day, it added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)